Furthermore, Bang-Berthelsen et al. reported that GLP-1RA liraglutide could alleviate colonic inflammation partially by downregulating CCL20 levels in a colitis mouse model (Bang-Berthelsen et al. 2016). This evidence concerns the gene CCL20 and colitis.